Boothbay Fund Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$826K Buy
1,774
+984
+125% +$414K 0.01% 1219
2026
Q1
$298K Buy
+790
New +$338K ﹤0.01% 1612
2025
Q4
Sell
-961
Closed -$430K 2015
2025
Q3
$430K Buy
961
+472
+97% +$214K 0.01% 1251
2025
Q2
$238K Buy
+489
New +$279K ﹤0.01% 1187
2024
Q3
Sell
-742
Closed -$403K 1650
2024
Q2
$403K Buy
+742
New +$425K 0.01% 1066
2023
Q2
Sell
-500
Closed -$269K 1877
2023
Q1
$269K Buy
500
+89
+22% +$45.4K 0.01% 1578
2022
Q4
$210K Sell
411
-286
-41% -$139K ﹤0.01% 1590
2022
Q3
$304K Buy
697
+154
+28% +$74.1K 0.01% 1527
2022
Q2
$255K Buy
+543
New +$265K 0.01% 1569
2021
Q4
Sell
-462
Closed -$215K 1896
2021
Q3
$215K Buy
+462
New +$218K 0.01% 1527

Other funds holding CHE

Boothbay Fund Management's CHE Position: Q2 2026 in Review

Boothbay Fund Management increased its Chemed (CHE) stake by 125% in Q2 2026, buying an estimated $414K and bringing the position to 1,774 shares worth $826K. The position accounts for 0.01% of the portfolio, ranked #1219.

Boothbay Fund Management first reported a position in CHE in Q3 2021 and has held it in 10 quarters since. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Boothbay Fund Management held 1,774 shares of Chemed worth $826K as of Q2 2026.
  • Boothbay Fund Management bought 984 Chemed shares in Q2 2026, an estimated $414K.
  • Chemed made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1219 holding.
  • Boothbay Fund Management first reported a position in Chemed in Q3 2021 and has held it in 10 quarters since.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.